Close Menu

depression

NEW YORK (GenomeWeb) – Northwestern University researchers have assessed a blood-based biomarker panel for major depressive disorder, reporting in Translational Psychiatry today that it could distinguish

NEW YORK (GenomeWeb) – Most plasma metabolites follow a daily rhythm in their expression levels that is muted by sleep deprivation, according to a metabolomic study appearing in the Proceedings of the National Academy of Sciences today.

NEW YORK (GenomeWeb) – Medicare contractor Palmetto GBA has issued draft local coverage determinations stipulating reimbursement criteria for three multi-marker molecular diagnostics: Assurex Health's pharmacogenetic test for refractory depression, MDxHealth's ConfirmMDx epigenetic prostate cance

NEW YORK (GenomeWeb) – Neuropsychiatric molecular diagnostics firm Assurex today said that it has secured a $25 million credit facility and $7 million in investments.
The funds will be used to increase clinical adoption of the Mason, Ohio-based firm's GeneSight products.

NEW YORK (GenomeWeb News) – Genomind, a firm developing genetic tests focused on psychiatry and neurology, announced today the closing of a $5 million financing round.

The National Institutes of Health this month awarded more than $400,000 in grant funding to support three research projects examining microRNAs in breast cancer, leukemia, and depression.

Despite initial setbacks, Myriad Genetics is moving ahead with development of protein biomarker panels for a variety of psychiatric disorders.

NEW YORK (GenomeWeb News) – Sundance Diagnostics today announced an exclusive, worldwide licensing deal with the Max Planck Institute of Psychiatry aimed at developing and commercializing a genetic test for predicting the risk of suicide from use of antidepressants.

NEW YORK (GenomeWeb News) – Investigators at Hartford Hospital's Genetics Research Center and Institute of Living will use a nearly $1.3 million federal grant to study the use of pharmacogenomic approaches in choosing medications for psychiatric patients.

Pages

The Washington Post reports that the CDC's SARS-CoV-2 test issues reflect earlier ones it had with Zika virus testing.

NPR writes that even with thousands of new COVID-19 papers, each should be evaluated based on its own quality.

Researchers traced a gene cluster linked to COVID-19 severity to Neanderthals, the New York Times reports.

In PNAS this week: soil bacteria-derived small molecules affect centrosomal protein, microfluidics approach for capturing circulating tumor cells, and more.